AU1322295A - Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection - Google Patents

Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection

Info

Publication number
AU1322295A
AU1322295A AU13222/95A AU1322295A AU1322295A AU 1322295 A AU1322295 A AU 1322295A AU 13222/95 A AU13222/95 A AU 13222/95A AU 1322295 A AU1322295 A AU 1322295A AU 1322295 A AU1322295 A AU 1322295A
Authority
AU
Australia
Prior art keywords
injection
protection against
vaccine compositions
yersinia pestis
bacterial vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13222/95A
Other languages
English (en)
Inventor
Angela Howells
Sophie Emma Clare Leary
Petra Claire Farquhar Oyston
Richard William Titball
Ethel Diane Williamson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Publication of AU1322295A publication Critical patent/AU1322295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU13222/95A 1993-12-24 1994-12-23 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection Abandoned AU1322295A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9326425 1993-12-24
GB939326425A GB9326425D0 (en) 1993-12-24 1993-12-24 Vaccine compositions
PCT/GB1994/002818 WO1995018231A1 (en) 1993-12-24 1994-12-23 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection

Publications (1)

Publication Number Publication Date
AU1322295A true AU1322295A (en) 1995-07-17

Family

ID=10747201

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13222/95A Abandoned AU1322295A (en) 1993-12-24 1994-12-23 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection

Country Status (6)

Country Link
EP (1) EP0741786A1 (de)
JP (1) JPH09507028A (de)
AU (1) AU1322295A (de)
CA (1) CA2179639A1 (de)
GB (1) GB9326425D0 (de)
WO (1) WO1995018231A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070043215A1 (en) * 1996-08-27 2007-02-22 Heath David G Recombinant f1-v plague vaccine
WO1998024912A2 (en) * 1996-12-04 1998-06-11 Heska Corporation Recombinant plague vaccine
EP1176966B1 (de) * 1999-04-12 2013-04-03 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Oligodeoxynukleotide und deren verwendung zur induktion einer immunreaktion
GB9921275D0 (en) * 1999-09-10 1999-11-10 Secr Defence Recombinant microorganisms
ATE378348T1 (de) 2000-01-14 2007-11-15 Us Health Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
GB0220257D0 (en) 2002-08-31 2002-10-09 Secr Defence Vaccine
US7344718B2 (en) 2003-01-31 2008-03-18 University Of North Dakota Yersinia species compositions
WO2012178078A2 (en) 2011-06-22 2012-12-27 University Of North Dakota Use of yscf, truncated yscf and yscf homologs as adjuvants
IN2014DN09618A (de) 2012-05-23 2015-07-31 Us Sec Dep Of Health And Human Services

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0474891A1 (de) * 1990-09-08 1992-03-18 BEHRINGWERKE Aktiengesellschaft Vektoren für die Expression malarialer Antigene an der Oberfläche von Salmonella Vakzinstämmen
JP3601602B2 (ja) * 1990-11-09 2004-12-15 ワシントン ユニバーシティ 無毒性微生物及びその使用：サルモネラ

Also Published As

Publication number Publication date
CA2179639A1 (en) 1995-07-06
GB9326425D0 (en) 1994-02-23
WO1995018231A1 (en) 1995-07-06
EP0741786A1 (de) 1996-11-13
JPH09507028A (ja) 1997-07-15

Similar Documents

Publication Publication Date Title
AU654093B2 (en) Curable carbamate-functional polymer composition
AU6045794A (en) PF1022 derivative cyclic depsipeptide
AU2746992A (en) Controlled release pharmaceutical compositions
AU4071595A (en) Live recombinant avian vaccine using an avian herpesvirus as vector
AU2553692A (en) Injection syringe
AU6125196A (en) Crop protection compositions
AU1242895A (en) Anti-fouling compositions
AU2969192A (en) Injection syringe
AU7713991A (en) Tgf-beta compositions
AU5914394A (en) Injection equipment
AU6630494A (en) Lignin-based formulations for wood composites
GB2309904B (en) Formulation auxiliaries for crop protection compositions
AU7483191A (en) Protection assembly for an injection syringe
ZA946195B (en) Anthelmintic formulations
AU3815793A (en) Blended fungicide compositions
AU1322295A (en) Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection
AU5989894A (en) Live coccidiosis vaccine
AU7084994A (en) Herbicidal compositions
AU658089B2 (en) Propylene polymer compositions
AU7919494A (en) Duct protection
AU7675891A (en) Methods for protecting against chemotherapy-induced hair loss
AU5134893A (en) Anaesthetic compositions
AU1229492A (en) Live vaccine against colibacillosis
AU7163694A (en) Curable compositions
AU4139393A (en) Barrier for protection against swell